Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.61M Buy
11,001
+6,046
+122% +$1.1M 0.46% 51
2026
Q1
$729K Buy
4,955
+67
+1% +$10.9K 0.24% 96
2025
Q4
$953K Buy
4,888
+81
+2% +$19.3K 0.32% 60
2025
Q3
$1.35M Sell
4,807
-756
-14% -$193K 0.49% 46
2025
Q2
$1.22M Buy
5,563
+48
+0.9% +$7.75K 0.48% 49
2025
Q1
$771K Sell
5,515
-181
-3% -$29.5K 0.41% 52
2024
Q4
$949K Buy
5,696
+123
+2% +$21.9K 0.48% 47
2024
Q3
$950K Buy
5,573
+632
+13% +$91.5K 0.78% 28
2024
Q2
$698K Buy
4,941
+156
+3% +$19.4K 0.45% 40
2024
Q1
$601K Buy
4,785
+199
+4% +$22.8K 0.67% 37
2023
Q4
$484K Buy
+4,586
New +$501K 0.61% 44

Other funds holding ORCL

Sunpointe's ORCL Position: Q2 2026 in Review

Sunpointe increased its Oracle (ORCL) stake by 122% in Q2 2026, buying an estimated $1.1M and bringing the position to 11,001 shares worth $1.61M. The position accounts for 0.46% of the portfolio, ranked #51.

Sunpointe first reported a position in ORCL in Q4 2023 and has held it in 11 quarters since. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Sunpointe held 11,001 shares of Oracle worth $1.61M as of Q2 2026.
  • Sunpointe bought 6,046 Oracle shares in Q2 2026, an estimated $1.1M.
  • Oracle made up 0.46% of Sunpointe's portfolio in Q2 2026, its #51 holding.
  • Sunpointe first reported a position in Oracle in Q4 2023 and has held it in 11 quarters since.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.